ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "meta-analysis"

  • Abstract Number: 2420 • 2014 ACR/ARHP Annual Meeting

    Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients with Rheumatoid Arthritis:  a Systematic Review

    Xin Pan1,2, Maria A. Lopez-Olivo2, Pratibha Nayak3 and Maria E. Suarez-Almazor4, 1Department of Rheumatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, 2Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 4The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Chinese herbal medicine (CHM) is a mainstay in the treatment of rheumatoid arthritis (RA) in China. We conducted a systematic review to appraise the…
  • Abstract Number: 2369 • 2014 ACR/ARHP Annual Meeting

    Management of Perioperative Tumor Necrosis -á Inhibitors in Rheumatoid Arthritis Undergoing Arthroplasty: A Systematic Review and Meta-Analysis

    Susan M. Goodman1, Indu Menon2, Rie Smethurst3, Paul Christos4 and Vivian P. Bykerk1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, NY, NY, 3Education - Academic Training, Hospital for Special Surgery, NY, NY, 4Healthcare Policy and Research, Weill Cornell Medical College, NY, NY

    Background/Purpose: Tumor Necrosis Factor α inhibitors (TNFi) are widely used in patients with RA (Rheumatoid Arthritis) undergoing orthopedic surgery, yet its optimal perioperative management is…
  • Abstract Number: 2337 • 2013 ACR/ARHP Annual Meeting

    Serious Adverse Events Associated With Using Biological Agents To Treat Rheumatic Diseases: Network Meta-Analysis From a National Guideline Panel

    Simon Tarp1, Ulrik Tarp2, Lis S. Andersen3, Tove Lorenzen4, Hanne M. Lindegaard5, Michael Stoltenberg6, Hanne S. Jensen7, Birgitte Brock8, Camilla M. Mikkelsen9, Dorte V. Jensen10, Karsten Asmussen7, Troels Herlin11 and Robin Christensen1, 1Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Rheumatology, Copenhagen University Hospital, Gentofte, Denmark, 4Department of Rheumatology, Region Hospital Silkeborg, Silkeborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, Denmark, 6Department of Rheumatology, Copenhagen University Hospital, Køge, Denmark, 7Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 8Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark, 9The Capital Region of Denmark Hospital Pharmacy, Medicine Information Centre, Copenhagen NV, Denmark, 10The Danish Rheumatologic Database (DANBIO), Center of Rheumatology and Spine Diseases VRR, Copenhagen University Hospital, Glostrup, Denmark, 11Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark

    Background/Purpose: Clinical guidelines are needed to help clinicians provide optimal medical treatment and advise patients about the potential hazards associated with certain drugs. Our objective…
  • Abstract Number: 1564 • 2013 ACR/ARHP Annual Meeting

    Efficacy Of Influenza Vaccination Is Strongly Decreased In Systemic Lupus Erythematosus: A Meta-Analysis Of Literature Data

    Laurent Arnaud1, Alexis Mathian2, Hervé Devilliers3, Du Boutin-LE Thi Huong4, Ahlem Chaib4, Fleur Cohen-Aubart4, Julien Haroche1, Miguel Hié4, Makoto Miyara4 and Zahir Amoura4, 1Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 2Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 3Internal medicine and systemic disease unit, Dijon University Hospital, Dijon, France, 4Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

    Background/Purpose: Several studies suggest that the efficacy of influenza vaccination may be decreased in systemic lupus erythematosus (SLE). We performed a meta-analysis to assess systematically…
  • Abstract Number: 1471 • 2013 ACR/ARHP Annual Meeting

    Tofacitinib For Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

    Maria A. Lopez-Olivo1, Maria E. Suarez-Almazor2 and Mahesh Bavineni3, 1General Internal Medicine, University of Texas. M.D Anderson Cancer Center, Houston, TX, 2The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 3Internal Medicine, Louisiana State University Lafayette, Lafayette, LA

    Background/Purpose: Tofacitinib was developed as a small molecule inhibitor of the Janus kinase (JAK) pathways that are central to the maintenance of the inflammatory state…
  • Abstract Number: 745 • 2013 ACR/ARHP Annual Meeting

    Rate Of Infection and Development Of Malignancy In Patients With ANCA-Associated Vasculitis Treated With Rituximab: A Meta-Analysis From Randomized Trials

    Carolina Mejia-Otero1, Carlos J. Lozada2 and Luis Arias-Urdaneta3, 1Internal Medicine, Mount Sinai Medical Center, Miami, FL, 2Dept of Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL, 3Rheumatology, Mount Sinai Medical Center, Miami Beach, FL

    Background/Purpose: Over the past 40 years failures to achieve remission in a proportion of patients and the potential development of significant adverse effects have been…
  • Abstract Number: 498 • 2013 ACR/ARHP Annual Meeting

    A Systematic Review and Meta-Analysis Comparing Low- Versus High-Dose Rituximab For Rheumatoid Arthritis

    Markus Bredemeier, Fernando K. de Oliveira and Claúdia M. Rocha, Rheumatology, Hospital Nossa Senhora da Conceição - Grupo Hospitalar Conceição, Porto Alegre, Brazil

    Background/Purpose: The approved dose of rituximab (RTX) for rheumatoid arthritis (RA) is 2x1000 mg infusions given 2 weeks apart. There is contradictory evidence regarding the…
  • Abstract Number: 460 • 2013 ACR/ARHP Annual Meeting

    Comparative Efficacy Of Novel Disease-Modifying Antirheumatic Drugs As Monotherapy and In Combination With Methotrexate In Rheumatoid Arthritis Patients With An Inadequate Response To Traditional Disease-Modifying Antirheumatic Drugs: A Network Meta-Analysis

    Felicity Buckley1, Axel Finckh2, Thomas W.J. Huizinga3, Fred Dejonckheere4 and Jeroen P. Jansen1, 1MAPI Consultancy, Boston, MA, 2Department of Medical Specialities, University of Geneva, Geneva, Switzerland, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4F. Hoffmann-La Roche Ltd, Basel, Switzerland

    Background/Purpose: To compare ACR responses of novel DMARDs as monotherapy or in combination with methotrexate (MTX), including subcutaneous (SC) abatacept and SC tocilizumab (TCZ), in…
  • Abstract Number: 472 • 2013 ACR/ARHP Annual Meeting

    Clinical Efficacy Rate Of The Non-Specific Effect (the placebo effect) In The Tumour Necrosis Factor Inhibitors For Rheumatoid Arthritis Treatment After Methotrexate Failure: Meta-Analysis

    Julie Azaïs1, Thomas Barnetche2, Pascale Vergne-Salle3, Christine Bonnet4, Carine Dufauret-Lombard5, Richard Treves6 and Philippe Bertin7, 1Rheumatology department, CHU Dupuytren Limoges, Limoges, France, 2Rheumatology, CHU Bordeaux Pellegrin, Bordeaux, France, 3Rheumatology, CHU Dupuytren Limoges, limoges, France, 4department of Rheumatology, CHU Dupuytren Limoges, Limoges, France, 5Rheumatology, CHU Dupuytren Limoges, Limoges, France, 6Department of Rheumatology, CHU Dupuytren Limoges, Limoges, France, 7Service De Rhumatologie, CHU Dupuytren Limoges, Limoges, France

    Background/Purpose: Therapeutics generate non-specific effects (the placebo effect), and specific ones, like the 5 tumor necrosis factor (TNF) inhibitors used in the treatment of Rheumatoid…
  • Abstract Number: 283 • 2013 ACR/ARHP Annual Meeting

    Efficacy Of Biologic Treatments In Juvenile Idiopathic Arthritis With a Polyarticular Course: An Indirect Comparison

    Laura Sawyer1, Alex Diamantopoulos2, Hermine Brunner3, Fabrizio De Benedetti4, Nicolino Ruperto5, Fred Dejonckheere6 and Caroline Keane7, 1Symmetron Limited, London, United Kingdom, 2Symmetron Limited, Herts, United Kingdom, 3PRCSG, Cincinnati, OH, 4Division of Rheumatology, Department of Pediatric Medicine, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 5PRINTO, Genoa, Italy, 6F. Hoffmann-La Roche Ltd, Basel, Switzerland, 7Roche, Welwyn Garden City, United Kingdom

    Background/Purpose: To date there are no head-to-head trials comparing the efficacy of biologic treatments for polyarticular-course JIA (pcJIA). The purpose of this study was to…
  • Abstract Number: 2685 • 2012 ACR/ARHP Annual Meeting

    Overall and Cause Specific Mortality in Patients with Systemic Lupus Erythematosus. A Meta-Analysis of Observational Studies

    Marko Yurkovich1, Kateryna Vostretsova2 and J. Antonio Avina-Zubieta3, 1Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada/University of British Columbia, Richmond, BC, Canada

    Background/Purpose:  Systemic lupus erythematosus (SLE), is a chronic autoimmune condition. It has the potential to affect any organ system and can be associated with severe…
  • Abstract Number: 2408 • 2012 ACR/ARHP Annual Meeting

    Effects of Ground and Joint Reaction Force Exercise On Bone Mineral Density in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials

    George A. Kelley1, Kristi S. Kelley1 and Wendy M. Kohrt2, 1Biostatistics, West Virginia University, Morgantown, WV, 2Geriatric Medicine, University of Colorado @ Denver, Aurora, CO

    Background/Purpose: Previous randomized controlled trials have led to conflicting findings regarding the effects of ground and/or joint reaction force exercise on femoral neck (FN) and…
  • Abstract Number: 2171 • 2012 ACR/ARHP Annual Meeting

    Comparative Efficacy of Biologics As Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with an Inadequate Response to Conventional Dmards: A Network Meta-Analysis

    Felicity Buckley1, Axel Finckh2, Thomas W. Huizinga3, Fred Dejonckheere4 and Jeroen P. Jansen1, 1MAPI Consultancy, Boston, MA, 2Rhumatology, University Hospital of Geneva, Geneva, Switzerland, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4F. Hoffmann-La Roche Ltd, Basel, Switzerland

    Background/Purpose: A number of meta-analyses compare the efficacy of biologics for rheumatoid arthritis (RA). However, systematic reviews comparing the efficacy of biologics as monotherapy versus…
  • Abstract Number: 1543 • 2012 ACR/ARHP Annual Meeting

    Rituximab for ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Trials

    Carolina Mejia1 and Carlos J. Lozada2, 1Internal Medicine, Mount Sinai Medical Center, Miami, FL, 2Dept of Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL

    Background/Purpose:  Over the past 40 years, cyclophosphamide/glucocorticoids combination therapy has been the standard regimen  for remission induction in ANCA-associated vasculitis.. Although a major advance in…
  • Abstract Number: 1052 • 2012 ACR/ARHP Annual Meeting

    Systematic Review of the Association Between Magnetic Resonance Imaging and Radiographic Detection of Erosions in Rheumatoid Arthritis

    Ruben Tavares1, Stephen R. Tytus2, Karen A. Beattie3, Maggie Larche4, Naveen Parasu5, Colin E. Webber6, Lawrence E. Hart7 and Jonathan D. Adachi8, 1McMaster University, Hamilton, ON, Canada, 2Northern Ontario School of Medicine, Sudbury, ON, Qatar, 3Medicine, McMaster University, Hamilton, ON, Canada, 4Rheumatology, McMaster University, Hamilton, ON, Canada, 5Radiology, Hamilton Health Sciences, Hamilton, ON, Canada, 6Department of Nuclear Medicine, Hamilton Health Sciences, Hamilton, ON, Canada, 7Medicine (Rheumatology), St. Joseph's Health Care, Hamilton, ON, Canada, 8St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: In rheumatoid arthritis (RA), disparities between erosive bone lesion detection on magnetic resonance imaging (MRI) and X-ray require reconciliation.  It is hypothesized that early…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology